StatLab Medical Products, a McKinney-based developer and manufacturer of medical diagnostic supplies and equipment, has acquired Scientific Device Laboratory, a Chicago-based manufacturer of printed diagnostic slides and a variety of consumables and kits for the anatomic pathology and microbiology markets.
StatLab said the acquisition of Scientific Device Laboratory (SDL) expands customer reach for both entities and provides a new U.S. research and development hub for the broader StatLab organization. Terms of the deal were not disclosed.
“The acquisition of SDL provides a terrific opportunity to expand our presence in the microbiology market and increase the reach of StatLab products into new customer segments and regions through SDL’s current channels,” StatLab CEO Sung-Dae Hong said in a statement. “Together with SDL’s founder, Dr. [Stewart] Lipton, our team is looking forward to accelerating product development and innovation, while continuing to serve existing customers by scaling SDL operations through the commercial and manufacturing resources that StatLab can offer.”
Lipton founded SDL more than 40 years ago after recognizing the need for customized clinical diagnostic products as a lab director at a major Chicago hospital. It manufactures customized products for OEMs, hospitals, and university laboratories, with a focus on printed diagnostic slides, control slides, and sample preparation products including mycobacterial test kits.
StatLab Executive Chairman Joe Bernardo called SDL “a unique acquisition” for his company.
“In conjunction with our newly added glass-slide manufacturing site in Germany, we’re able to better service the existing customers of both StatLab and SDL through a dual-continent footprint for both glass manufacturing and R&D,” Bernardo added in a statement. “This exemplifies the strength of our strategic differentiation through diverse manufacturing capabilities.”
‘Legacy of solving problems for our customers’
Lipton said the combination builds on his company’s legacy.
“This decision to combine forces with StatLab will be transformative for our business,” Lipton said. “Through scaling and optimizing the manufacturing of our core products, and by empowering us to focus on additional research to create new, innovative products, this transaction builds on SDL’s legacy of solving problems for our customers.”
The company said that Lipton will continue in his leadership role at the SDL manufacturing site in the near-term, and as StatLab continues to grow, he will shift focus to R&D and innovation as the combined company further scales its operations.
Last year, StatLab launched a new manufacturing facility in Arlington after acquiring two UK-based histology consumables and diagnostic equipment companies in 2021 and 2022.
Injection molding operations at the new 35,000-square-foot Arlington facility will give laboratories the confidence of additional U.S.-produced core histology consumables including cassettes, the company said.
Get on the list.
Dallas Innovates, every day.
Sign up to keep your eye on what’s new and next in Dallas-Fort Worth, every day.